These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26501222)

  • 1. Predictive Value of EuroSCORE II in Patients Undergoing Left Ventricular Assist Device Therapy.
    Menon AK; Mechelinck M; Unterkofler J; Goetzenich A; Autschbach R; Tewarie L; Moza A
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):475-82. PubMed ID: 26501222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
    Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
    J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients.
    Adamo L; Nassif M; Tibrewala A; Novak E; Vader J; Silvestry SC; Itoh A; Ewald GA; Mann DL; LaRue SJ
    JACC Heart Fail; 2015 Apr; 3(4):283-90. PubMed ID: 25770410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
    Teuteberg JJ; Ewald GA; Adamson RM; Lietz K; Miller LW; Tatooles AJ; Kormos RL; Sundareswaran KS; Farrar DJ; Rogers JG
    J Am Coll Cardiol; 2012 Jul; 60(1):44-51. PubMed ID: 22541834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
    Kanwar MK; Lohmueller LC; Kormos RL; Loghmanpour NA; Benza RL; Mentz RJ; Bailey SH; Murali S; Antaki JF
    ASAIO J; 2017; 63(3):251-256. PubMed ID: 27984320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
    Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
    Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HeartMate Risk Score Identifies Patients With Similar Mortality Risk Across All INTERMACS Profiles in a Large Multicenter Analysis.
    Adamo L; Tang Y; Nassif ME; Novak E; Jones PG; LaRue S; Spertus JA; Mann DL
    JACC Heart Fail; 2016 Dec; 4(12):950-958. PubMed ID: 27614939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent risk factors for ICU mortality after left ventricular assist device implantation.
    Piffard M; Nubret-Le Coniat K; Simon O; Leuillet S; Rémy A; Barandon L; Ouattara A
    Artif Organs; 2020 Feb; 44(2):153-161. PubMed ID: 31318978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk Score.
    Birati EY; Hanff TC; Maldonado D; Grandin EW; Kennel PJ; Mazurek JA; Vorovich E; Seigerman M; Howard JLL; Acker MA; Naka Y; Wald J; Goldberg LR; Jessup M; Atluri P; Margulies KB; Schulze PC; Rame JE
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HeartMate II Left Ventricular Assist Device Pump Exchange: A Single-Institution Experience.
    Shaikh AF; Joseph SM; Lima B; Hall SA; Malyala R; Rafael AE; Gonzalez-Stawinski GV; Chamogeorgakis T
    Thorac Cardiovasc Surg; 2017 Aug; 65(5):410-414. PubMed ID: 27903010
    [No Abstract]   [Full Text] [Related]  

  • 20. Temporal Analysis in Outcomes of Long-Term Mechanical Circulatory Support: Retrospective Study.
    Ondrusek M; Artemiou P; Bezak B; Gasparovic I; By TM; Durdik S; Lesny P; Goncalvesova E; Hulman M
    Thorac Cardiovasc Surg; 2024 Oct; 72(7):521-529. PubMed ID: 38641334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.